Global Benchtop NGS Sequencers Market Growth 2026-2032
Description
The global Benchtop NGS Sequencers market size is predicted to grow from US$ 773 million in 2025 to US$ 1688 million in 2032; it is expected to grow at a CAGR of 12.0% from 2026 to 2032.
The desktop NGS sequencer is a compact, next-generation high-throughput sequencing device that is easy to use on the laboratory desktop. It provides fast and accurate gene sequence analysis capabilities. Its advantages are small size, easy installation and maintenance, while maintaining efficient data output and high-quality sequencing results. Features include a user-friendly operating interface, short sequencing time, low cost, and high sequencing throughput, making the desktop NGS sequencer an ideal gene analysis tool in scientific research and clinical laboratories, especially for small and medium-scale sequencing projects.
United States market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Benchtop NGS Sequencers players cover Illumina, ELEMENT BIOSCIENCES, CD Genomics, Singular Genomics Systems, Spectrum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Benchtop NGS Sequencers Industry Forecast” looks at past sales and reviews total world Benchtop NGS Sequencers sales in 2025, providing a comprehensive analysis by region and market sector of projected Benchtop NGS Sequencers sales for 2026 through 2032. With Benchtop NGS Sequencers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Benchtop NGS Sequencers industry.
This Insight Report provides a comprehensive analysis of the global Benchtop NGS Sequencers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Benchtop NGS Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Benchtop NGS Sequencers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Benchtop NGS Sequencers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Benchtop NGS Sequencers.
This report presents a comprehensive overview, market shares, and growth opportunities of Benchtop NGS Sequencers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA Library Preparation
RNA Library Preparation
ChIP Library Preparation
Segmentation by Application:
Clinical Testing
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
ELEMENT BIOSCIENCES
CD Genomics
Singular Genomics Systems
Spectrum
Thermo Fisher
QIAGEN
Perkin Elmer
Agilent Technologies
Tecan
Beckman Coulter
INTEGRA Biosciences AG
AUTOMATA
Difei Medical Technology (Nanjing)
Hangzhou Matridx Biotechnology
Shanghai 3D Medicines
MobiDrop (Zhejiang)
GUANGDONG MGI TECH
Key Questions Addressed in this Report
What is the 10-year outlook for the global Benchtop NGS Sequencers market?
What factors are driving Benchtop NGS Sequencers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benchtop NGS Sequencers market opportunities vary by end market size?
How does Benchtop NGS Sequencers break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The desktop NGS sequencer is a compact, next-generation high-throughput sequencing device that is easy to use on the laboratory desktop. It provides fast and accurate gene sequence analysis capabilities. Its advantages are small size, easy installation and maintenance, while maintaining efficient data output and high-quality sequencing results. Features include a user-friendly operating interface, short sequencing time, low cost, and high sequencing throughput, making the desktop NGS sequencer an ideal gene analysis tool in scientific research and clinical laboratories, especially for small and medium-scale sequencing projects.
United States market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Benchtop NGS Sequencers players cover Illumina, ELEMENT BIOSCIENCES, CD Genomics, Singular Genomics Systems, Spectrum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Benchtop NGS Sequencers Industry Forecast” looks at past sales and reviews total world Benchtop NGS Sequencers sales in 2025, providing a comprehensive analysis by region and market sector of projected Benchtop NGS Sequencers sales for 2026 through 2032. With Benchtop NGS Sequencers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Benchtop NGS Sequencers industry.
This Insight Report provides a comprehensive analysis of the global Benchtop NGS Sequencers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Benchtop NGS Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Benchtop NGS Sequencers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Benchtop NGS Sequencers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Benchtop NGS Sequencers.
This report presents a comprehensive overview, market shares, and growth opportunities of Benchtop NGS Sequencers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA Library Preparation
RNA Library Preparation
ChIP Library Preparation
Segmentation by Application:
Clinical Testing
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
ELEMENT BIOSCIENCES
CD Genomics
Singular Genomics Systems
Spectrum
Thermo Fisher
QIAGEN
Perkin Elmer
Agilent Technologies
Tecan
Beckman Coulter
INTEGRA Biosciences AG
AUTOMATA
Difei Medical Technology (Nanjing)
Hangzhou Matridx Biotechnology
Shanghai 3D Medicines
MobiDrop (Zhejiang)
GUANGDONG MGI TECH
Key Questions Addressed in this Report
What is the 10-year outlook for the global Benchtop NGS Sequencers market?
What factors are driving Benchtop NGS Sequencers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benchtop NGS Sequencers market opportunities vary by end market size?
How does Benchtop NGS Sequencers break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
141 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Benchtop NGS Sequencers by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Benchtop NGS Sequencers by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


